Post hoc analyses of East Asian patients from the randomized placebo-controlled PREVAIL trial of enzalutamide in patients with chemotherapy-naïve, metastatic castration-resistant prostate cancer-Reference-Cited by-同舟云学术

Post hoc analyses of East Asian patients from the randomized placebo-controlled PREVAIL trial of enzalutamide in patients with chemotherapy-naïve, metastatic castration-resistant prostate cancer

Published:2017-07 Issue:27 Volume:96 Page:e7223
ISSN:0025-7974
Container-title:Medicine
language:en
Short-container-title:

Author:

Kim Choung Soo,Choi Young Deuk,Lee Sang Eun,Lee Hyun Moo,Ueda Takeshi,Yonese Junji,Fukagai Takashi,Chiong Edmund,Lau Weber,Abhyankar Sarang,Theeuwes Ad,Tombal Bertrand,Beer Tomasz M.,Kimura Go

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

General Medicine

Reference31 articles.

1. Prostate cancer in Asian men;Ito;Nat Rev Urol,2014

2. The change of prostate cancer treatment in Korea: 5 year analysis of a single institution;Lee;Yonsei Med J,2013

3. The worldwide epidemiology of prostate cancer: perspectives from autopsy studies;Haas;Can J Urol,2008

4. Cancer incidence and incidence rates in Japan in 2007: a study of 21 population-based cancer registries for the Monitoring of Cancer Incidence in Japan (MCIJ) project;Matsuda;Jpn J Clin Oncol,2013

5. Cancer statistics in Korea: incidence, mortality, survival, and prevalence in 2012;Jung;Cancer Res Treat,2015

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Oncological Outcomes in Men with Metastatic Castration-Resistant Prostate Cancer Treated with Enzalutamide with versus Without Confirmatory Bone Scan;Cancer Research and Treatment;2023-12-05

2. Novel hormonal therapies in the management of advanced prostate cancer: extrapolating Asian findings to Southeast Asia;BMC Urology;2023-01-06

3. Enzalutamide in Chemotherapy-Naïve Metastatic Castration-Resistant Prostate Cancer: An Asian Multiregional, Randomized Study;Advances in Therapy;2022-04-10

4. Ethnic Pharmacogenomic Differences in the Management of Asian Patients with Metastatic Prostate Cancer;Cancers;2022-01-14

5. High Tumor Burden Predicts Poor Response to Enzalutamide in Metastatic Castration-Resistant Prostate Cancer Patients;Cancers;2021-08-05